Document ID: chunk:federal_register_of_legislation:F2024C01137:reg:2:p5
Version: federal_register_of_legislation:F2024C01137
Segment Type: reg
Provision Reference: reg 2 (pt 5/6)
Character Range: 31860–34832

the Reporting Entity.

2.2.5 Reporting Requirement—Continuity of reporting
(1) Subject to subrule (2), a Reporting Entity that reports to a Derivative Trade Repository (in this Rule, the Original Trade Repository):
         1.         information about a Reportable Transaction in an OTC Derivative, in accordance with subrule 2.2.1(1); or
         2.        a change to information referred to in paragraph (a), in accordance with subrule 2.2.2(1);
must take all reasonable steps to ensure that it reports further information or changes that relate to the same OTC Derivative, to the Original Trade Repository.
(2) If the Reporting Entity or the person that reports on its behalf is no longer a participant of the Original Trade Repository, or the Reporting Entity is no longer able to comply with subrule 2.2.1(1) or 2.2.2(1) by reporting the information or change to the Original Trade Repository, the information or change must be reported to another Licensed Repository or Prescribed Repository in accordance with the requirements of this Part.

2.2.6 Reporting Requirement—Accuracy of reporting
A Reporting Entity must take all reasonable steps to ensure that information it reports under subrule 2.2.1(1) and any change to that information it reports under subrule 2.2.2(1), whether reported by the Reporting Entity on its own behalf or by another person on behalf of the Reporting Entity, is and remains at all times complete, accurate and current.

2.2.7 Derivative Transaction Information—Delegation of reporting
A Reporting Entity may appoint one or more persons to report on behalf of the Reporting Entity in accordance with Rules 2.2.1 to 2.2.5 and 2.2.8.
Note: For example, the Reporting Entity may appoint a counterparty of the Reporting Entity, central counterparty, operator of a financial market, service provider, broker or any other third party.

2.2.8 Lifecycle or snapshot reporting
(1) A Reporting Entity that is not a Small-scale Buy-side Entity must report Derivative Transaction Information for each Reportable Transaction in an OTC Derivative that takes place on a day, in accordance with the Rules.
(2) A Reporting Entity that is a Small-scale Buy-side Entity must report Derivative Transaction Information for each Reportable Transaction in an OTC Derivative that is an equity derivative that takes place on a day, in accordance with the Rules.
(3) A Reporting Entity that is a Small-scale Buy-side Entity may comply with Rule 2.2.1 in relation to a Reportable Transaction in an OTC Derivative (Relevant OTC Derivative) that is not an equity derivative at the time the Reportable Transaction is entered into, that takes place on a day (Relevant Day) by:
         1.         reporting Derivative Transaction Information for each Reportable Transaction in the Relevant OTC Derivative; or
         2.        reporting Derivative Transaction Information in relation to the Relevant OTC Derivative on its terms as of the Relevant Day;
and otherwise